Avalo Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
AVTX
CUSIP
05338F306
Type
Equity
Class
COM NEW
Num filings
135
Total reported value, excl. options
$1.34 B
Manager Report Date Value ($000) Shares Option Type